United States · Platforms & data · Finviz

Xenon to Report Q3 2026 Financial Results on November 9, 2026

Published by Finviz · United States 9 h ago

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

Seeking Alpha

Empire State Realty Trust FFO of $0.20 beats by $0.02, revenue of $193.05M beats by $4.34M

The Motley Fool

AMD Reports Tuesday. Here's the Number That Will Show Whether It's Gaining on Nvidia

MarketWatch

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

Investing.com

People Inc earnings missed by $8.96, revenue fell short of estimates

CNBC

Texas governor race tightens in prediction markets, but Abbott remains favored

Benzinga